Brevan Howard Capital Management LP Biodesix Inc Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Biodesix Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 10,525 shares of BDSX stock, worth $16,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,525Holding current value
$16,840% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BDSX
# of Institutions
45Shares Held
16.2MCall Options Held
0Put Options Held
0-
Birchview Capital, LP Burlington, VT5.19MShares$8.31 Million6.38% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.32MShares$5.31 Million1.91% of portfolio
-
Telemark Asset Management, LLC Boston, MA1.33MShares$2.12 Million0.22% of portfolio
-
Essex Investment Management CO LLC Boston, MA926KShares$1.48 Million0.27% of portfolio
-
Wells Fargo & Company San Francisco, CA893KShares$1.43 Million0.0% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $64M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...